Glycogen Synthase Kinase 3
Glycogen synthase kinase 3 (GSK-3) is a serine-threonine kinase with two isoforms (α and β ), that was originally discovered as an important enzyme in glycogen metabolism. GSK-3 was subsequently shown to function in cellular division, proliferation, motility and survival.
Products for Glycogen Synthase Kinase 3 - Page 2
- Cat.No. Product Name Information/Activity
-
BCC3898
MeBIO
667463-95-8
-
BCC7208
NSC 693868
40254-90-8
-
BCC3650
SB 216763
SB 216763 is potent, selective and ATP-competitive GSK-3 inhibitor with IC50s of 34.3 nM for both GSK-3α and GSK-3β.
-
BCC3651
SB 415286
Potent, selective GSK-3 inhibitor,SB415286 is a potent GSK3α inhibitor with IC50/Ki of 78 nM/31 nM with equally effective inhibition of GSK-3β.
-
BCC6146
TC-G 24
1257256-44-2
-
BCC6074
TCS 2002
1005201-24-0
-
BCC2443
TCS 21311
TCS 21311 (NIBR3049) is a potent, highly selective JAK3 inhibitor with an IC50 of 8 nM, it displays >100-fold selectivity over JAK1, JAK2 and TYK2. TCS 21311 (NIBR3049) inhibits PKCα, PKCθ, and GSK3β with IC50s of 13, 68, and 3 nM, respectively.
-
BCC5817
2B-(SP)
186901-17-7
-
BCC5747
Phospho-Glycogen Synthase Peptide-2 (substrate)
851366-97-7
-
BCC5899
TCS 184
1315378-71-2
